Evidence map›Paper›PMID 40513026›Full record

Trial reportThe New England journal of medicine2025

Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.

Kathryn Maitland, San Maurice Ouattara, Hadiza Sainna, Abdullahi Chara, Oluwakemi F Ogundipe, Temmy Sunyoto, M Hamaluba, Peter Olupot-Olupot, Florence Alaroker, Roisin Connon and 14 more

Abstract readClinical Trial, Phase IIEquivalence TrialMulticenter Study
In one paragraph

Trial report in The New England journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Kathryn MaitlandInstitute of Global Health and Innovation, Department of Surgery and Cancer, Imperial College London, London.ORCID 0000-0002-0007-0645
San Maurice OuattaraImperial College London, London.ORCID 0000-0002-4329-0445
Hadiza SainnaMédecins Sans Frontières, Maiduguri, Nigeria.
Abdullahi CharaMédecins Sans Frontières, Maiduguri, Nigeria.
Oluwakemi F OgundipeMédecins Sans Frontières, Brussels.
Temmy SunyotoMédecins Sans Frontières, Brussels.
M HamalubaKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
Peter Olupot-OlupotBusitema University Faculty of Health Sciences, Mbale Regional Referral Hospital, Mbale, Uganda.
Florence AlarokerSoroti Regional Referral Hospital, Soroti, Uganda.
Roisin ConnonMedical Research Council Clinical Trials Unit at University College London, London.
Amadou Saidou MaguinaMédecins Sans Frontières, Magaria, Niger.
William OkirorBusitema University Faculty of Health Sciences, Mbale Regional Referral Hospital, Mbale, Uganda.
Denis AmorutSoroti Regional Referral Hospital, Soroti, Uganda.
Eric MwajomboKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
Emmanuel OgudaKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
Christabel MogakaKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
Céline LangendorfEpicentre, Paris.
Juan Emmanuel DewezLondon School of Hygiene and Tropical Medicine, London.
Iza CigleneckiMédecins Sans Frontières, Geneva.
Diana M GibbMedical Research Council Clinical Trials Unit at University College London, London.
Matthew E ColdironEpicentre, Paris.ORCID 0000-0002-3345-5971
Roberta PetrucciMédecins Sans Frontières, Geneva.
Elizabeth C GeorgeMedical Research Council Clinical Trials Unit at University College London, London.
GASTROSAM Trial Group

Funding

Medical Research Council MR/R018502/1Medical Research Council Canada MR/R018502/1Wellcome Trust
6 · The paper itself

Abstract

backgroundInternational recommendations advise against the use of intravenous rehydration therapy in children with severe acute malnutrition because of the concern about fluid overload, but evidence to support this concern is lacking. Given the high mortality associated with the current recommendations, the adoption of intravenous rehydration strategies might improve outcomes.

methodsWe conducted a factorial, open-label superiority trial in four countries in Africa. Children 6 months to 12 years of age with severe acute malnutrition with gastroenteritis and dehydration underwent randomization in a 2:1:1 ratio to one of three rehydration strategies: oral rehydration, plus intravenous boluses for shock; a rapid intravenous strategy that consisted of lactated Ringer's solution (100 ml per kilogram of body weight) administered over a period of 3 to 6 hours, with boluses for shock; or a slow intravenous strategy that consisted of the same solution administered over a period of 8 hours, with no boluses. The primary end point was death at 96 hours.

resultsA total of 272 children underwent randomization; 138 were assigned to the oral strategy, 67 to the rapid intravenous strategy, and 67 to the slow intravenous strategy. Participants were followed for 28 days. A nasogastric tube was used for oral rehydration in 126 of 135 participants (93%) in the oral group and in 82 of 126 (65%) in the intravenous groups. Intravenous boluses were administered at admission in 12 participants (9%) in the oral group, 7 (10%) in the rapid intravenous group, and none in the slow intravenous group. At 96 hours, 11 participants (8%) in the oral group and 9 (7%) in the intravenous groups (5 in the rapid group and 4 in the slow group) had died (risk ratio, 1.02; 95% confidence interval [CI], 0.41 to 2.52; P = 0.69). At 28 days, 17 participants (12%) in the oral group and 14 (10%) in the intravenous groups had died (hazard ratio, 0.85; 95% CI, 0.41 to 1.78). Serious adverse events occurred in 32 participants (23%) in the oral group, 14 (21%) in the rapid intravenous group, and 10 (15%) in the slow intravenous group. No evidence of pulmonary edema, heart failure, or fluid overload was noted.

conclusionsAmong children with severe acute malnutrition and gastroenteritis, no evidence of a difference in mortality at 96 hours was noted between oral and intravenous rehydration strategies. (Funded by the Joint Global Health Trials scheme and others; GASTROSAM Current Controlled Trials number, ISRCTN76149273.).

Indexed as

DehydrationFluid TherapyGastroenteritisSevere Acute MalnutritionAdministration, OralAfricaChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfusions, IntravenousKaplan-Meier EstimateMaleRehydration SolutionsRehydration SolutionsRinger's Lactate

Identifiers

PMID40513026
PMCPMC7617792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.